Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers
Ho, M K, Mwenifumbo, J C, Al Koudsi, N, Okuyemi, K S, Ahluwalia, J S, Benowitz, N L, Tyndale, R F
Published in Clinical pharmacology and therapeutics (01.06.2009)
Published in Clinical pharmacology and therapeutics (01.06.2009)
Get more information
Journal Article
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age
Desta, Z, Kreutz, Y, Nguyen, A T, Li, L, Skaar, T, Kamdem, L K, Henry, N L, Hayes, D F, Storniolo, A M, Stearns, V, Hoffmann, E, Tyndale, R F, Flockhart, D A
Published in Clinical pharmacology and therapeutics (01.11.2011)
Published in Clinical pharmacology and therapeutics (01.11.2011)
Get more information
Journal Article
CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion
Zhu, A Z X, Cox, L S, Nollen, N, Faseru, B, Okuyemi, K S, Ahluwalia, J S, Benowitz, N L, Tyndale, R F
Published in Clinical pharmacology and therapeutics (01.12.2012)
Published in Clinical pharmacology and therapeutics (01.12.2012)
Get more information
Journal Article
Biomarkers for smoking cessation
Bough, K J, Lerman, C, Rose, J E, McClernon, F J, Kenny, P J, Tyndale, R F, David, S P, Stein, E A, Uhl, G R, Conti, D V, Green, C, Amur, S
Published in Clinical pharmacology and therapeutics (01.06.2013)
Published in Clinical pharmacology and therapeutics (01.06.2013)
Get more information
Journal Article
The pharmacogenetics research network: from SNP discovery to clinical drug response
Giacomini, K M, Brett, C M, Altman, R B, Benowitz, N L, Dolan, M E, Flockhart, D A, Johnson, J A, Hayes, D F, Klein, T, Krauss, R M, Kroetz, D L, McLeod, H L, Nguyen, A T, Ratain, M J, Relling, M V, Reus, V, Roden, D M, Schaefer, C A, Shuldiner, A R, Skaar, T, Tantisira, K, Tyndale, R F, Wang, L, Weinshilboum, R M, Weiss, S T, Zineh, I
Published in Clinical pharmacology and therapeutics (01.03.2007)
Published in Clinical pharmacology and therapeutics (01.03.2007)
Get more information
Journal Article
Breaking barriers in the genomics and pharmacogenetics of drug addiction
Ho, M K, Goldman, D, Heinz, A, Kaprio, J, Kreek, M J, Li, M D, Munafò, M R, Tyndale, R F
Published in Clinical pharmacology and therapeutics (01.12.2010)
Published in Clinical pharmacology and therapeutics (01.12.2010)
Get more information
Journal Article
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment
Jukić, M M, Opel, N, Ström, J, Carrillo-Roa, T, Miksys, S, Novalen, M, Renblom, A, Sim, S C, Peñas-Lledó, E M, Courtet, P, Llerena, A, Baune, B T, de Quervain, D J, Papassotiropoulos, A, Tyndale, R F, Binder, E B, Dannlowski, U, Ingelman-Sundberg, M
Published in Molecular psychiatry (01.08.2017)
Published in Molecular psychiatry (01.08.2017)
Get full text
Journal Article
Differential effects of nicotine treatment and ethanol self-administration on CYP2A6, CYP2B6 and nicotine pharmacokinetics in African green monkeys
Ferguson, C S, Miksys, S, Palmour, R M, Tyndale, R F
Published in The Journal of pharmacology and experimental therapeutics (01.12.2012)
Published in The Journal of pharmacology and experimental therapeutics (01.12.2012)
Get full text
Journal Article
Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion
Patterson, F, Schnoll, R A, Wileyto, E P, Pinto, A, Epstein, L H, Shields, P G, Hawk, L W, Tyndale, R F, Benowitz, N, Lerman, C
Published in Clinical pharmacology and therapeutics (01.09.2008)
Published in Clinical pharmacology and therapeutics (01.09.2008)
Get more information
Journal Article
A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes
Messina, E S, Tyndale, R F, Sellers, E M
Published in The Journal of pharmacology and experimental therapeutics (01.09.1997)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.09.1997)
Journal Article
Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy
Lerman, C, Jepson, C, Wileyto, E P, Patterson, F, Schnoll, R, Mroziewicz, M, Benowitz, N, Tyndale, R F
Published in Clinical pharmacology and therapeutics (01.05.2010)
Published in Clinical pharmacology and therapeutics (01.05.2010)
Get more information
Journal Article